Basit öğe kaydını göster

dc.contributor.authorAltiparmak, Mehmet Rıza
dc.contributor.authorApaydin, Süheyla
dc.contributor.authorAtaman, R
dc.contributor.authorErek, E
dc.contributor.authorOzturk, Recep
dc.contributor.authorSerdengecti, K
dc.date.accessioned2021-03-03T20:00:41Z
dc.date.available2021-03-03T20:00:41Z
dc.date.issued2000
dc.identifier.citationApaydin S., Altiparmak M. R. , Serdengecti K., Ataman R., Ozturk R., Erek E., "Mycobacterium tuberculosis infections after renal transplantation", SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, cilt.32, sa.5, ss.501-505, 2000
dc.identifier.issn0036-5548
dc.identifier.othervv_1032021
dc.identifier.otherav_5797284e-c79d-4f1f-b20a-d4b67d7a2ed2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/61773
dc.description.abstractThe incidence of tuberculosis was found to be 5.8% (16/274) in 274 kidney graft recipients in our centre between 1986 and 1998, The kidney recipients were evaluated retrospectively. A total of 51 recipients received isoniazid prophylaxis for 6 months. The prevalence of tuberculosis was found similar (6% vs. 8,8%, p = 0.15) between recipients with prophylaxis and no prophylaxis, Eight patients were recipients of cadaveric donor kidneys and 8 were recipients of living donor kidneys. Lungs were the most frequently affected site, as in the normal population. M, tuberculosis grew in 7 patients. In 5 patients, M. tuberculosis was also detected on direct microscopy and polymerase chain reaction. In 4 patients, diagnosis was made on clinical grounds and later confirmed by positive response to therapy. In 8 patients, invasive procedures were performed for diagnosis. Five patients had miliary tuberculosis at the time of diagnosis. In 3 patients dissemination occurred during follow-up. Nine patients responded to anti-tuberculous therapy while still preserving their graft function, 1 patient rejected the graft while under treatment and returned to haemodialysis. Five patients (31%) died. Since the risk of dissemination of tuberculosis is high in these patients, anti-tuberculous therapy should be started whenever clinical findings suggestive of tuberculosis are present, even in the absence of any microbiological and/or histological evidence.
dc.language.isoeng
dc.subjectİmmünoloji
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleMycobacterium tuberculosis infections after renal transplantation
dc.typeMakale
dc.relation.journalSCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume32
dc.identifier.issue5
dc.identifier.startpage501
dc.identifier.endpage505
dc.contributor.firstauthorID41724


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster